Revvity, Inc
$16.48B- Market cap
- $14.18B
- Debt
- +$3.22B
- Cash
- −$919.86M
Capital structure 81% equity / 19% debt · EV / Revenue 5.77x · EV / EBITDA 21.65x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $14.18B · View financials
Snapshot Sep 8, 2026, 4:00 PM ET
FY 2025 ·
Decision snapshot: RVTY stock price vs NXPI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NXPI's multiple
Needs NXPI P/E.
Implied fair value · at RVTY's multiple
Needs Annual EPS.
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RVTY FY 2025 (ended Dec 28, 2025) · NXPI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
11 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 81% equity / 19% debt · EV / Revenue 5.77x · EV / EBITDA 21.65x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REVVITY, INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
NXP Semiconductors N.V. · implied price per share
The ordinary-share to listed-security ratio could not be verified.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.44x
1.22x
Net debt / EBITDA
Leverage against operating earnings
3.02x
2.17x
Cash and equivalents
Liquid reserves on the balance sheet
$919.86M
$3.27B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AGILENT TECHNOLOGIES, INC.
RVTY vs A
WATERS CORP /DE/
RVTY vs WAT
BIO-RAD LABORATORIES, INC.
RVTY vs BIO
METTLER TOLEDO INTERNATIONAL INC/
RVTY vs MTD
DANAHER CORP /DE/
RVTY vs DHR
THERMO FISHER SCIENTIFIC INC.
RVTY vs TMO
Qualcomm Incorporated
RVTY vs QCOM
Broadcom Inc.
RVTY vs AVGO
Texas Instruments Incorporated
RVTY vs TXN
NVIDIA Corporation
RVTY vs NVDA
Intel Corporation
RVTY vs INTC
$3.22B
$12.29B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.